Novartis AG (NYSE:NVS) is one of the 11 best European stocks to invest in. On June 23, the company confirmed it had completed ...

The transaction was approved by both companies' boards and includes a significant premium over recent stock prices for ...

Basel: Novartis has announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. With the ...

Novartis today announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. ("Regulus"). With ...

Novartis today announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. (“Regulus”). With the completion of the acquisition, shares of common stock, par value $0.001 ...

Novartis today announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. ("Regulus").

Novartis has announced the expiration of its tender offer to acquire Regulus Therapeutics Inc., marking a significant step ...

Bhatt was just 26 when she was diagnosed with polycystic kidney disease (PKD)—a condition she discovered by chance while ...

Sanofi paid a more than 300% premium on its acquisition of Vigil Neuroscience, suggesting a fierce battle to seal the deal.

The ABI, a simple, noninvasive physiological test, remains the cornerstone for initial diagnosis of PAD, although it has multiple limitations, particularly in the setting of diabetes and chronic ...

SEOUL, South Korea, June 12, 2025 /PRNewswire/ -- Mezzion Pharma Co., Ltd. (Mezzion), a leader in rare disease therapeutics, today announced the expansion of its udenafil pipeline with the initiation ...

Her father, Daniel, said he has been battling kidney disease for four years and needed a transplant to maintain a normal life. “I was on dialysis. I had a tube in my stomach,” he said.